Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.30 is 314% above its 3-year average of -0.14, near the high end of its 3-year range (-4.19–0.76).
As of the fiscal period ended Tuesday, June 30, 2026. 20.33% below its 12-month average of 0.37.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.30.
DEBT TO EQUITY RATIO
0.30
DEBT TO EQUITY RATIO AVG TTM
0.37
DEBT TO EQUITY RATIO AVG 3Y
-0.20
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-20.33%
CURRENT VS 3Y AVG
+249.48%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.14
median of 475 covered companies
CURRENT VS SECTOR MEDIAN
+112.10%
vs the sector median at left
Market Cap
$51.78M
Debt to Equity Ratio
0.25
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$51.96M
Debt to Equity Ratio
0.00
TTM Avg
0.12
3Y Avg
0.06
5Y Avg
0.04
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| eXoZymes, Inc. (EXOZ) | $51.51M | 0.30 | 0.37 | -0.20 | N/A |
| INmune Bio, Inc. (INMB)vs › | $51.71M | 0.07 | 0.03 | 0.14 | 0.13 |
| Envoy Medical, Inc. (COCH)vs › | $51.78M | 0.25 | 0.00 | 0.00 | 0.00 |
| biote Corp. (BTMD)vs › | $50.72M | N/A | 9.05 | 9.05 | 9.05 |
| Apollomics, Inc. (APLM)vs › | $50.51M | N/A | 0.15 | 0.15 | 0.15 |
| Celularity Inc. (CELU)vs › | $50.90M | N/A | 4.70 | 2.51 | 1.98 |
| Clene Inc. (CLNN)vs › | $49.58M | N/A | 6.12 | 6.71 | 4.67 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.96M | 0.00 | 0.12 | 0.06 | 0.04 |
| ImageneBio Inc (IMA)vs › | $53.01M | 0.01 | 0.07 | 0.06 | 0.05 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $54.79M | 0.02 | 0.01 | 0.01 | 0.00 |
Debt/Equity
0.30
Current Ratio
3.81
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.30 |
| 2026-03-31 | 0.76 |
| 2025-12-31 | 0.37 |
| 2025-09-30 | 0.25 |
| 2025-06-30 | 0.19 |
| 2025-03-31 | 0.15 |
| 2024-12-31 | 0.13 |
| 2024-09-30 | -1.35 |
| 2024-06-30 | -1.93 |
| 2024-03-31 | -1.25 |
| 2023-12-31 | -4.19 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.44 |
